← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 31, 2007Last known activity
Aug 31, 2023
Timeline
2000s
- Jan 1, 2005
Eastern Health, Canada— Founded
Drugs by trial phase (15 distinct, 10 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Anemia
- Communicable Diseases
- Coronavirus Infections
- Embolism
- Infections
- Kidney Diseases
- Multiple Pulmonary Nodules
- Multiple Sclerosis
- Neoplasms
- Prostatic Neoplasms
- Pulmonary Embolism
- Renal Insufficiency, Chronic
- Sclerosis
- Severe Acute Respiratory Syndrome
- Solitary Pulmonary Nodule
- Thrombosis
- Tremor
- Venous Thrombosis
Recent trials (13)
- NCT05788081CollaboratorPhase 2Aug 31, 2023
- NCT05760807CollaboratorN/AMar 29, 2023
- NCT05182931CollaboratorPhase 2Jul 14, 2022
- NCT04615156Lead sponsorPhase 3Nov 1, 2020
- NCT04615156Reponsible party - principal investigatorPhase 3Nov 1, 2020
- NCT04421664CollaboratorPhase 3Mar 25, 2020
- NCT02446405Study chairPhase 3Mar 1, 2014
- NCT01252420CollaboratorPhase 4Nov 1, 2010
- NCT02817555Lead sponsorPhase 4Sep 1, 2010
- NCT02817555Overall official - principal investigatorPhase 4Sep 1, 2010
- NCT02817555Sponsor investigatorPhase 4Sep 1, 2010
- NCT01018485CollaboratorPhase 3Oct 1, 2008
- NCT00528008CollaboratorPhase 3Dec 31, 2007
Details
- Founded
- St. John's, CA Jan 1, 2005
- Last known activity
- Aug 31, 2023